Literature DB >> 19961395

Determination of serum holotranscobalamin concentrations with the AxSYM active B(12) assay: cut-off point evaluation in the clinical laboratory.

Fabrizia Bamonti1, Giovanna Antonella Moscato, Cristina Novembrino, Dario Gregori, Claudia Novi, Rachele De Giuseppe, Claudio Galli, Valentina Uva, Silvia Lonati, Rita Maiavacca.   

Abstract

BACKGROUND: A reliable early marker is required for diagnosis of cobalamin deficiency. We calculated an appropriate holotranscobalamin (HoloTC) cut-off point for identifying cobalamin deficiency using an immunoenzymatic assay.
METHODS: Determination of the cut-off threshold and correlation between HoloTC and the other diagnostic parameters routinely used for vitamin B(12) deficiency [total vitamin B(12) (tB(12)), folate, homocysteine] were measured in 250 routine blood specimens from 107 men (mean age 59.0+/-18.8 years) and 143 women (mean age 54.2+/-23.1 years). The inclusion criterion was serum tB(12) concentration <or=221 pmol/L.
RESULTS: Analytical performance results agreed with those reported by others. A weak correlation (R=0.42) was found between HoloTC and tB(12). A 40 pmol/L cut-off threshold was chosen for HoloTC and the associated sensitivity and specificity was 0.86 and 0.66, respectively. Out of 250 tested samples, 126 showed tB(12) concentrations 139-221 pmol/L (gray zone, GZ) and 124 had tB(12) concentrations <139 pmol/L (low, L). Values less than the cut-off for HoloTC were present in 68.2% and 37.9% of cases in the GZ and L group, respectively (p<0.01), and in 53.2% of subjects.
CONCLUSIONS: Our results confirmed the analytical reliability of the AxSYM HoloTC assay. The method is adequate for routine use and a cut-off threshold of 40 pmol/L is appropriate for assessing cobalamin deficiency in populations with reduced tB(12) values.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19961395     DOI: 10.1515/CCLM.2010.032

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  10 in total

1.  Vitamin B12 deficiency: there's more than meets the eye.

Authors:  Claudio Galli
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

Review 2.  Perspective: Practical Approach to Preventing Subclinical B12 Deficiency in Elderly Population.

Authors:  Alessandra Vincenti; Laura Bertuzzo; Antonio Limitone; Giuseppe D'Antona; Hellas Cena
Journal:  Nutrients       Date:  2021-06-02       Impact factor: 5.717

3.  Holotranscobalamin is a useful marker of vitamin B12 deficiency in alcoholics.

Authors:  Alberto Fragasso; Clara Mannarella; Angela Ciancio; Oronzo Scarciolla; Nicoletta Nuzzolese; Rocco Clemente; Eustachio Vitullo; Andrea Sacco
Journal:  ScientificWorldJournal       Date:  2012-03-12

4.  Assessment of the vitamin B12 status of pregnant women in Nigeria using plasma holotranscobalamin.

Authors:  Dorothy J Vanderjagt; Innocent A O Ujah; Eugene I Ikeh; Jessica Bryant; Victor Pam; Amelia Hilgart; Michael J Crossey; Robert H Glew
Journal:  ISRN Obstet Gynecol       Date:  2011-07-14

Review 5.  Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility.

Authors:  Ebba Nexo; Elke Hoffmann-Lücke
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

6.  Vitamin B12 and folate levels in healthy Swiss senior citizens: a prospective study evaluating reference intervals and decision limits.

Authors:  Martin Risch; Dominik W Meier; Benjamin Sakem; Pedro Medina Escobar; Corina Risch; Urs Nydegger; Lorenz Risch
Journal:  BMC Geriatr       Date:  2015-07-11       Impact factor: 3.921

7.  An encapsulated juice powder concentrate improves markers of pulmonary function and cardiovascular risk factors in heavy smokers.

Authors:  Fabrizia Bamonti; Marco Pellegatta; Cristina Novembrino; Luisella Vigna; Rachele De Giuseppe; Federica de Liso; Dario Gregori; Cinzia Della Noce; Lorenzo Patrini; Gianfranco Schiraldi; Paola Bonara; Laura Calvelli; Rita Maiavacca; Giuliana Cighetti
Journal:  J Am Coll Nutr       Date:  2013       Impact factor: 3.169

8.  Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment.

Authors:  Alessandro Fulgenzi; Rachele De Giuseppe; Fabrizia Bamonti; Maria Elena Ferrero
Journal:  Biomed Res Int       Date:  2014-07-10       Impact factor: 3.411

Review 9.  Holotranscobalamin (HoloTC, Active-B12) and Herbert's model for the development of vitamin B12 deficiency: a review and alternative hypothesis.

Authors:  Paul Henry Golding
Journal:  Springerplus       Date:  2016-05-20

10.  Homocysteine metabolism in children and adolescents with epidermolysis bullosa.

Authors:  Rachele De Giuseppe; Greta Venturelli; Sophie Guez; Simona Salera; Claudia De Vita; Dario Consonni; Cinzia Dellanoce; Fabrizia Bamonti; Gabriella Chiarelli; Francesca Manzoni; Rita Maiavacca; Susanna Esposito
Journal:  BMC Pediatr       Date:  2016-10-29       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.